Is It Time for Quotas to Achieve Racial and Ethnic Representation in Multiple Sclerosis Trials?
作者信息
Mateen Farrah J
机构信息
Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States.
出版信息
Front Neurol. 2021 May 13;12:680912. doi: 10.3389/fneur.2021.680912. eCollection 2021.
Abstract
摘要
相似文献
1
Is It Time for Quotas to Achieve Racial and Ethnic Representation in Multiple Sclerosis Trials?
Front Neurol. 2021 May 13;12:680912. doi: 10.3389/fneur.2021.680912. eCollection 2021.
2
The Case Against Race-Based Quotas in Pharmaceutical Trials.
Am J Law Med. 2023 Mar;49(1):1-23. doi: 10.1017/amj.2023.13. Epub 2023 Jun 28.
3
Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999.
J Natl Med Assoc. 2001 Dec;93(12 Suppl):18S-24S.
4
Gender quotas for women in national politics: A comparative analysis across development thresholds.
Soc Sci Res. 2017 Aug;66:82-101. doi: 10.1016/j.ssresearch.2017.01.008. Epub 2017 Feb 2.
5
Race and Ethnicity in the Evidence for Integrating Palliative Care Into Oncology.
J Oncol Pract. 2018 Jun;14(6):e346-e356. doi: 10.1200/JOP.17.00016. Epub 2018 May 29.
6
Risk for spontaneous preterm birth among inter-racial/ethnic couples.
J Matern Fetal Neonatal Med. 2018 Mar;31(5):633-639. doi: 10.1080/14767058.2017.1293029. Epub 2017 Apr 12.
7
Demographic data in asthma clinical trials: a systematic review with implications for generalizing trial findings and tackling health disparities.
Soc Sci Med. 2009 Oct;69(8):1147-54. doi: 10.1016/j.socscimed.2009.06.012. Epub 2009 Jul 9.
8
Disparities in Racial and Ethnic Representation in Stem Cell Clinical Trials.
Stud Health Technol Inform. 2020 Jun 26;272:358-361. doi: 10.3233/SHTI200569.
9
National Trends in the Prevalence of Chronic Kidney Disease Among Racial/Ethnic and Socioeconomic Status Groups, 1988-2016.
JAMA Netw Open. 2020 Jul 1;3(7):e207932. doi: 10.1001/jamanetworkopen.2020.7932.
10
Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review.
JAMA Netw Open. 2019 Nov 1;2(11):e1914745. doi: 10.1001/jamanetworkopen.2019.14745.
引用本文的文献
1
Representation of ethnic and racial minority groups in European vaccine trials: a quantitative analysis of clinical trials registries.
BMJ Public Health. 2023 Oct 18;1(1):e000042. doi: 10.1136/bmjph-2023-000042. eCollection 2023 Nov.
2
Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review.
Trials. 2025 Feb 22;26(1):65. doi: 10.1186/s13063-025-08769-y.
3
Understanding the Symptoms and Impacts Experienced by People with Relapsing-Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews.
Neurol Ther. 2024 Apr;13(2):449-464. doi: 10.1007/s40120-024-00584-y. Epub 2024 Feb 12.
4
Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple Sclerosis.
Int J MS Care. 2024 Jan-Feb;26(1):36-40. doi: 10.7224/1537-2073.2023-004. Epub 2024 Jan 5.
5
Long-term trajectories of ambulatory impairment in multiple sclerosis.
Mult Scler. 2023 Sep;29(10):1282-1295. doi: 10.1177/13524585231187521. Epub 2023 Jul 28.
6
Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients.
Front Immunol. 2023 May 5;14:1172993. doi: 10.3389/fimmu.2023.1172993. eCollection 2023.
7
Twenty-year trends in racial and ethnic enrollment in large diabetes randomized controlled trials.
BMC Med. 2022 Sep 16;20(1):294. doi: 10.1186/s12916-022-02501-2.
8
Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion.
NPJ Digit Med. 2022 May 5;5(1):58. doi: 10.1038/s41746-022-00603-y.
9
Women's Health in Multiple Sclerosis: A Scoping Review.
Front Neurol. 2022 Jan 31;12:812147. doi: 10.3389/fneur.2021.812147. eCollection 2021.
10
Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers.
Ann Clin Transl Neurol. 2022 Feb;9(2):155-170. doi: 10.1002/acn3.51499. Epub 2022 Feb 1.
本文引用的文献
1
Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans.
Sci Rep. 2020 Oct 9;10(1):16902. doi: 10.1038/s41598-020-74035-7.
2
Assessment of Racial/Ethnic Disparities in Volumetric MRI Correlates of Clinical Disability in Multiple Sclerosis: A Preliminary Study.
J Neuroimaging. 2021 Jan;31(1):115-123. doi: 10.1111/jon.12788. Epub 2020 Sep 19.
3
Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada.
Mult Scler. 2021 Jun;27(7):1027-1036. doi: 10.1177/1352458520948212. Epub 2020 Aug 11.
4
Multiple sclerosis in a multi-ethnic population from Northern California: a retrospective analysis, 2010-2016.
BMC Neurol. 2020 Apr 30;20(1):163. doi: 10.1186/s12883-020-01749-6.
5
Race and ethnicity on MS presentation and disease course.
Mult Scler. 2020 Apr;26(5):561-567. doi: 10.1177/1352458519887328. Epub 2020 Jan 22.
6
MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics.
Nutrients. 2018 Feb 27;10(3):268. doi: 10.3390/nu10030268.
7
The More Things Change, the More They Stay the Same: A Study to Evaluate Compliance With Inclusion and Assessment of Women and Minorities in Randomized Controlled Trials.
Acad Med. 2018 Apr;93(4):630-635. doi: 10.1097/ACM.0000000000002027.
8
Challenging Assumptions About African American Participation in Alzheimer Disease Trials.
Am J Geriatr Psychiatry. 2017 Oct;25(10):1150-1159. doi: 10.1016/j.jagp.2017.04.013. Epub 2017 Apr 25.
9
Needs, Priorities, and Recommendations for Engaging Underrepresented Populations in Clinical Research: A Community Perspective.
J Community Health. 2017 Jun;42(3):472-480. doi: 10.1007/s10900-016-0279-2.
10
Inadequacy of clinical trial designs and data to control for the confounding impact of race/ethnicity in response to treatment in multiple sclerosis.
JAMA Neurol. 2014 Aug;71(8):943-4. doi: 10.1001/jamaneurol.2014.79.
Zotero 插件